Development of a novel strategy for the determination of Ag(I), Cu(II) and Ni(II) in urine after the extraction mediated by a semipermeable membrane

IF 3.1 3区 医学 Q2 CHEMISTRY, ANALYTICAL Journal of pharmaceutical and biomedical analysis Pub Date : 2025-08-15 Epub Date: 2025-03-27 DOI:10.1016/j.jpba.2025.116837
Karoline D. do Amaral, Pamela S.M. Rocha, André S. Araújo, Ricardo J. Cassella
{"title":"Development of a novel strategy for the determination of Ag(I), Cu(II) and Ni(II) in urine after the extraction mediated by a semipermeable membrane","authors":"Karoline D. do Amaral,&nbsp;Pamela S.M. Rocha,&nbsp;André S. Araújo,&nbsp;Ricardo J. Cassella","doi":"10.1016/j.jpba.2025.116837","DOIUrl":null,"url":null,"abstract":"<div><div>The determination of metals in urine using spectrometric techniques presents challenges due to the complex matrix of substances in the samples. This work introduces a novel method for determining Ag(I), Cu(II), and Ni(II) in urine using a semipermeable membrane device (SPMD) filled with chloroform (CHCl₃). The analytes were separated after complexation with ammonium pyrrolidinedithiocarbamate (APDC), forming a substance capable of migrating through the membrane and being absorbed by the internal phase. After extraction, the internal phase (solvent) was transferred to a volumetric flask, diluted with ethanol, and analyzed by graphite furnace atomic absorption spectrometry (GF AAS). Optimization of the extraction process included the acceptor phase, sample pH, APDC concentration, extraction time, and GF AAS temperature program. The limits of detection were 0.19, 0.23, and 0.15 µg L⁻¹ for Ag(I), Cu(II), and Ni(II), respectively, while the limits of quantification were 0.64, 0.77, and 0.51 µg L⁻¹ . Analysis of five urine samples and recovery tests, involving spiking with 5 and 10 µg L⁻¹ of each analyte, resulted in recovery percentages between 85 % and 106 %, confirming the suitability of the method for quantifying metals in complex samples like urine.</div></div>","PeriodicalId":16685,"journal":{"name":"Journal of pharmaceutical and biomedical analysis","volume":"261 ","pages":"Article 116837"},"PeriodicalIF":3.1000,"publicationDate":"2025-08-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of pharmaceutical and biomedical analysis","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0731708525001785","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/3/27 0:00:00","PubModel":"Epub","JCR":"Q2","JCRName":"CHEMISTRY, ANALYTICAL","Score":null,"Total":0}
引用次数: 0

Abstract

The determination of metals in urine using spectrometric techniques presents challenges due to the complex matrix of substances in the samples. This work introduces a novel method for determining Ag(I), Cu(II), and Ni(II) in urine using a semipermeable membrane device (SPMD) filled with chloroform (CHCl₃). The analytes were separated after complexation with ammonium pyrrolidinedithiocarbamate (APDC), forming a substance capable of migrating through the membrane and being absorbed by the internal phase. After extraction, the internal phase (solvent) was transferred to a volumetric flask, diluted with ethanol, and analyzed by graphite furnace atomic absorption spectrometry (GF AAS). Optimization of the extraction process included the acceptor phase, sample pH, APDC concentration, extraction time, and GF AAS temperature program. The limits of detection were 0.19, 0.23, and 0.15 µg L⁻¹ for Ag(I), Cu(II), and Ni(II), respectively, while the limits of quantification were 0.64, 0.77, and 0.51 µg L⁻¹ . Analysis of five urine samples and recovery tests, involving spiking with 5 and 10 µg L⁻¹ of each analyte, resulted in recovery percentages between 85 % and 106 %, confirming the suitability of the method for quantifying metals in complex samples like urine.
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
半透膜提取尿液中银(I)、铜(II)和镍(II)的新方法的建立
由于样品中物质的复杂基质,使用光谱技术测定尿液中的金属提出了挑战。这项工作介绍了一种用氯仿(CHCl₃)填充的半透膜装置(SPMD)测定尿液中Ag(I), Cu(II)和Ni(II)的新方法。分析物与吡咯烷二硫代氨基甲酸铵(APDC)络合后分离,形成一种能够通过膜迁移并被内相吸收的物质。提取后,内相(溶剂)转移到容瓶中,用乙醇稀释,用石墨炉原子吸收光谱法(GF AAS)分析。提取工艺的优化包括受体相、样品pH、APDC浓度、提取时间和GF AAS温度程序。银(I)、铜(II)和镍(II)的检测限分别为0.19、0.23和0.15 µg L⁻¹ ,定量限分别为0.64、0.77和0.51 µg L⁻¹ 。对5个尿液样本进行分析和回收率测试,包括每种分析物的5和10 µg L⁻¹ ,结果回收率在85 %和106 %之间,证实了该方法用于定量尿液等复杂样品中的金属的适用性。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
CiteScore
6.70
自引率
5.90%
发文量
588
审稿时长
37 days
期刊介绍: This journal is an international medium directed towards the needs of academic, clinical, government and industrial analysis by publishing original research reports and critical reviews on pharmaceutical and biomedical analysis. It covers the interdisciplinary aspects of analysis in the pharmaceutical, biomedical and clinical sciences, including developments in analytical methodology, instrumentation, computation and interpretation. Submissions on novel applications focusing on drug purity and stability studies, pharmacokinetics, therapeutic monitoring, metabolic profiling; drug-related aspects of analytical biochemistry and forensic toxicology; quality assurance in the pharmaceutical industry are also welcome. Studies from areas of well established and poorly selective methods, such as UV-VIS spectrophotometry (including derivative and multi-wavelength measurements), basic electroanalytical (potentiometric, polarographic and voltammetric) methods, fluorimetry, flow-injection analysis, etc. are accepted for publication in exceptional cases only, if a unique and substantial advantage over presently known systems is demonstrated. The same applies to the assay of simple drug formulations by any kind of methods and the determination of drugs in biological samples based merely on spiked samples. Drug purity/stability studies should contain information on the structure elucidation of the impurities/degradants.
期刊最新文献
E-nose, HS-SPME-GC-MS and untargeted metabolomics reveal effects on 60Co gamma irradiation of Neng-An-Jun-Ning Pills: Changes in odor and chemical compositions Isolation and identification of the designer benzodiazepine cyclopropylflualprazolam in pressed candies marketed for sleep improvement Polysaccharide-driven quality control of Gastrodia elata Blume: A multidimensional strategy integrating LC-MS/MS-based quantitative analysis, machine learning, and anti-neuroinflammatory bioactivity Unraveling the heterogeneity of hyperuricemia using untargeted metabolomics and statistical modeling Untargeted LC-MS-based metabolic fingerprinting of Escherichia coli-associated urinary tract infections and urosepsis: Insights into the urine, serum, and bacterial interactomes
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1